Tacrolimus

CAS 104987-11-3

In Stock

Tacrolimus

Cat. No. ANT-TRC-00CAS 104987-11-3In Stock

Technical Data

Cat. No.ANT-TRC-00

CAS104987-11-3

Mol. FormulaC₄₄H₆₉NO₁₂

Mol. Weight804.03 g/mol

IUPAC(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone

SMILESC[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC

InChIInChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1

InChI KeyQJJXYPPXXYFBGM-LFZNUXCKSA-N

PurityNA

Description

Overview

Tacrolimus is an immunosuppressive drug sold under the brand names Protopic and Program. After allogeneic organ transplantation, the risk of organ rejection is moderate. To reduce the risk of organ rejection, tacrolimus is given

Anant Labs manufacture and furnish high quality Tacrolimus impurities for global markets. Our Tacrolimus EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexa deca hydro -5,19-dihydroxy-3-[(1E)-2-[(1R, 3R, 4R) -4-hydroxy-3-methoxy cyclo hexyl]-1-methyl ethenyl]-14,16-dimethoxy-4,10,12,18-tetra methyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxa aza cyclotricosine-1,7,20,21(4H,23H)-tetronetacrolimusFujimycin104987-11-3PrografTsukubaenolideProtopicTacrolimus anhydrousFK506Modigraf

Browse APIs A–Z